Combating Cardiovascular Disease with Compounded Medications -- Part 2: Clinical and Compounding Issues for Antihypertensive Drugs
Author(s): Harrington Catherine A, Cauffield Jacintha
Issue: May/Jun 2005 - Veterinary Compounding
View All Articles in Issue
Page(s): 201-205
Download in electronic PDF format for $65
Abstract: Selection of the “best” antihypertensive therapy was an issue of great debate among clinicians in the past. As large meta-analytic studies have shown, all antihypertensive drugs lower blood pressure by about the same amount; the main differences are in their side effects, cost, and frequency of administration. The side effect profiles, along with the patient’s comorbid conditions, should determine the combination of drugs to use. For the most part, side effects from antihypertensive drugs are predictable since they are dose related. When hypertension coexists with other cardiac conditions, drugs that treat both hypertension and other conditions at the same time should be chosen. Physicians should be encouraged to aggressively pursue treatment goals in hypertension, and meta-analysis has shown that combination drug therapy is the best way to reduce doses and side effects while maintaining effectiveness in blood pressure control. Compounded combinations let physicians tailor prescriptions to the patient; individualizing the mix of drugs and doses allows more aggressive treatment while controlling side effects and cost of therapy.
Related Keywords:
Catherine A. Harrington, PharmD, PhD, Jacintha Cauffield, PharmD, BCPS, hypertension, high blood pressure, antihypertensive medication, combination drug regimens, adverse effects, side effects, drug costs
Related Articles from IJPC |
Title/Author
(Click for Abstract / Details / Purchase) |
Issue/Page
View/Buy |
Combating Cardiovascular Disease with Compounded Medications -- Part 2: Clinical and Compounding Issues for Antihypertensive Drugs
Harrington Catherine A, Cauffield Jacintha
|
May/Jun 2005
Pg. 201-205
|
Veterinary Transdermal Medications: A to Z
Davidson Gigi S
|
Mar/Apr 2003
Pg. 106-113
|
Combating Cardiovascular Disease With Compounded Medications. Part 1: Combination Cardiac Medicines to Control Blood Pressure
Harrington Catherine A, Cauffield Jacintha
|
Mar/Apr 2005
Pg. 117-119
|
Novel Approaches to Topical Psoriasis Therapy
Koyama Gregory, Liu Jenny, Scaffidi Alyse, Khazraee Maryam, Epstein Benjamin
|
Sep/Oct 2015
Pg. 357-365
|
Pain: Systematic Review of Pharmacy Compounding of Pain Medication
Shawaqfeh Mohammad S, Harrington Catherine
|
Jan/Feb 2018
Pg. 19-24
|
Efficacy and Clinical Value of Commonly Used Ingredients in Pain Management Compounds: A Literature Review
Beshay Sarah M, Rivera Gerard, Balthasar Jan, Florea Naomi
|
Jul/Aug 2015
Pg. 295-300
|
Incorporating Quality Assurance in Pharmaceutical Compounding-related Courses in the PharmD Curricula
Hossain Mohammad Faisal, Levesque Dan, Frye John, Rashid Mamoon
|
Jul/Aug 2020
Pg. 322-326
|
The Role of Compounding Pharmacists During Drug Shortages
Ofei Kelvin
|
Jul/Aug 2022
Pg. 298-301
|
The Effects of Compounded Bioidentical Transdermal Hormone Therapy on Hemostatic, Inflammatory, and Immune Factors; Cardiovascular Biomarkers; Quality of Life Measures; and Health Outcomes in Perimenopausal and Postmenopausal Women
Stephenson Kenna, Neuenschwander Pierre F, Kurdowska Anna K
|
Jan/Feb 2013
Pg. 74-85
View Sample |
Pharmacogenomics: Precision Pharmacy in 503A Compounding
Drummond Joseph, Bennet Daron, Allen Loyd V Jr
|
Mar/Apr 2018
Pg. 95-107
|